- The Quantiferon-TB Gold Plus blood test is designed to detect latent tuberculosis in patients.
- Teva Pharmaceuticals gained approval for the first generic version of Gilead Science’s best-selling HIV drug Truvada.
- Symjepi is a single-dose prefilled syringe of epinephrine intended to treat emergency allergic reactions, including anaphylaxis.
- Mydayis is intended to treat ADHD symptoms in patients thirteen years or older.
- Cotempla is an extended-release orally disintegrating tablet intended to treat ADHD in patients ages 6 to 17 years.
- Baxdela is intended to treat skin and skin structure infections caused by various gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus.
- Haegarda is the first self-administered C1 esterase inhibitor subcutaneous injection to prevent swelling attacks in patients with hereditary angiodema.
More articles on supply chain:
Drug manufacturer, distributor shut down for producing unapproved medications
Sanofi CEO on SCOTUS’ biologics ruling: 3 takeaways
Whole Foods acquisition could move Amazon closer to pharmacies
